Your browser doesn't support javascript.
loading
CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26).
Kim, Ji-Hea; Kang, Ka-Won; Park, Yong; Kim, Byung Soo.
Affiliation
  • Kim JH; Institute of Stem Cell Research, Korea University College of Medicine, Seoul, South Korea.
  • Kang KW; Department of Biomedical Science, Graduate School of Medicine, Korea University, Seoul, South Korea.
  • Park Y; Department of Internal Medicine, Anam Hospital Korea University Medical Center, Seoul, South Korea.
  • Kim BS; Department of Internal Medicine, Anam Hospital Korea University Medical Center, Seoul, South Korea.
Heliyon ; 9(11): e22091, 2023 Nov.
Article in En | MEDLINE | ID: mdl-38045173
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2023 Document type: Article Affiliation country: Corea del Sur Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2023 Document type: Article Affiliation country: Corea del Sur Country of publication: Reino Unido